GPT and urticaria: Adverse events were observed in 15 (42.9%) subjects, nine with transient and mild alanine aminotransferase increases, two with gastrointestinal discomfort, one with mild folliculitis, one with urticaria, one with dizziness, and one with headache (all CTCAE grade 1).